Prevalence of GJB2 gene mutations correlated to presence of clinical and environmental risk factors in the etiology of congenital sensorineural hearing loss of the Romanian population
Although etiologically heterogeneous at least 50% of all early on-set hearing losses have a genetic cause and of these, the large majority, 75-80% are most probably autosomal recessive and 70% are non-syndromic. The rest of the congenital hearing losses are determined by clinical and environmental f...
Gespeichert in:
Veröffentlicht in: | Experimental and therapeutic medicine 2021-06, Vol.21 (6), p.612, Article 612 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 6 |
container_start_page | 612 |
container_title | Experimental and therapeutic medicine |
container_volume | 21 |
creator | Neagu, Alexandra Mocanu, Adela-Ioana Bonciu, Alexandru Coadă, Gabriella Mocanu, Horia |
description | Although etiologically heterogeneous at least 50% of all early on-set hearing losses have a genetic cause and of these, the large majority, 75-80% are most probably autosomal recessive and 70% are non-syndromic. The rest of the congenital hearing losses are determined by clinical and environmental factors such as ototoxic medication, prematurity, and complications at birth. During the last decade it became clear that 50-80% of all such afflictions result from mutations in a single gene,
, which encodes the protein Connexin 26. In order to, at least partially clarify this problem, especially in an emerging country such as Romania, where the problem is not studied adequately, we developed a comprehensive study of genetic, clinical and environmental risk factors for congenital hearing loss. The two most common variations of this gene,
and
in children with positive diagnosis of bilateral severe to profound sensorineural hearing loss were investigated. A cohort of 34 children (20 female and 14 male), ages between 2 and 10 (mean age 4.62 years), coming from 33 non-related families were evaluated. All cases were diagnosed with severe or profound bilateral congenital SNHL. A statistical comparison of genetic and environmental/clinical prevalence was also attempted since the presence of a genetic disorder cannot rule out the role of other documented risk factors in the etiology of SNHL. The results showed that, 29.4% of cases (10/34) were homozygotic for the
mutation
), also known as genotype Δ/Δ. 5.88% of cases (2/34) belong to the heterozygotic bi-genic group
. The clinical factors with high statistical significance for SNHL in a non-genetic group have no significance for genetic SNHL patients. Thus, the present study confirms the relatively high prevalence of the
and
mutations in cases of congenital non-syndromic severe of profound bilateral SNHL. |
doi_str_mv | 10.3892/etm.2021.10044 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8082587</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A662836135</galeid><sourcerecordid>A662836135</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-a7d2726785edcb3dcfd3a4038f2abd3cc78b62fa0dc3a1d0a762e9291b40e89e3</originalsourceid><addsrcrecordid>eNptkstu1DAUhiMEolXpliWyxIbNDL7EibNBKlVpQZVACNaWY59kXBJ7sJOR-mS8Xk-Gabmo9sK37_z2Of6L4iWja6Ea_hamcc0pZ2tGaVk-KY5Z3fAVo0w-Pcxpo9hRcZrzDcUmK6aUfF4cCdGIilfNcfHrS4KdGSBYILEjl5_ec9JDADLOk5l8DJnYmBIMZgJHpki2CfI9bQcfvDUDMcERCDufYhghTLiTfP5BOmOnmDLxgUwbIIB6Q-xv96Ex4DV-QVEux-QDzAlXGzA478kQc17AJfBrHE3wJpBt3M7D_lkvimedGTKcHsaT4vuHi2_nV6vrz5cfz8-uV7ZkclqZ2vGaV7WS4GwrnO2cMCUVquOmdcLaWrUV7wx1VhjmqKkrDg1vWFtSUA2Ik-Ldb93t3I6ogdnhK_U2-dGkWx2N1_-eBL_RfdxpRRWXqkaBNweBFH_OkCc9-mxhGEyAOGfNJWeSlkJwRF__h97EOQVMb6FKxqgU7A_V47dpH7qI99pFVJ9VFVeiYkIitX6Ewu5g9Fh86DzuPxZgE1Y-QfeQI6N6cZtGt-nFbXrvNgx49XdlHvB7b4k7DijUWA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2524110531</pqid></control><display><type>article</type><title>Prevalence of GJB2 gene mutations correlated to presence of clinical and environmental risk factors in the etiology of congenital sensorineural hearing loss of the Romanian population</title><source>PubMed Central</source><creator>Neagu, Alexandra ; Mocanu, Adela-Ioana ; Bonciu, Alexandru ; Coadă, Gabriella ; Mocanu, Horia</creator><creatorcontrib>Neagu, Alexandra ; Mocanu, Adela-Ioana ; Bonciu, Alexandru ; Coadă, Gabriella ; Mocanu, Horia</creatorcontrib><description>Although etiologically heterogeneous at least 50% of all early on-set hearing losses have a genetic cause and of these, the large majority, 75-80% are most probably autosomal recessive and 70% are non-syndromic. The rest of the congenital hearing losses are determined by clinical and environmental factors such as ototoxic medication, prematurity, and complications at birth. During the last decade it became clear that 50-80% of all such afflictions result from mutations in a single gene,
, which encodes the protein Connexin 26. In order to, at least partially clarify this problem, especially in an emerging country such as Romania, where the problem is not studied adequately, we developed a comprehensive study of genetic, clinical and environmental risk factors for congenital hearing loss. The two most common variations of this gene,
and
in children with positive diagnosis of bilateral severe to profound sensorineural hearing loss were investigated. A cohort of 34 children (20 female and 14 male), ages between 2 and 10 (mean age 4.62 years), coming from 33 non-related families were evaluated. All cases were diagnosed with severe or profound bilateral congenital SNHL. A statistical comparison of genetic and environmental/clinical prevalence was also attempted since the presence of a genetic disorder cannot rule out the role of other documented risk factors in the etiology of SNHL. The results showed that, 29.4% of cases (10/34) were homozygotic for the
mutation
), also known as genotype Δ/Δ. 5.88% of cases (2/34) belong to the heterozygotic bi-genic group
. The clinical factors with high statistical significance for SNHL in a non-genetic group have no significance for genetic SNHL patients. Thus, the present study confirms the relatively high prevalence of the
and
mutations in cases of congenital non-syndromic severe of profound bilateral SNHL.</description><identifier>ISSN: 1792-0981</identifier><identifier>EISSN: 1792-1015</identifier><identifier>DOI: 10.3892/etm.2021.10044</identifier><identifier>PMID: 33936269</identifier><language>eng</language><publisher>Greece: Spandidos Publications</publisher><subject>Birth defects ; Deafness ; Environmental risk ; Enzymes ; Etiology ; Families & family life ; Gene mutations ; Genes ; Genetic aspects ; Genotype & phenotype ; Health aspects ; Hearing disorders in children ; Hearing loss ; Hypoxia ; Mutation ; Parents & parenting ; Pediatric research ; Risk factors ; Statistical analysis ; Variables</subject><ispartof>Experimental and therapeutic medicine, 2021-06, Vol.21 (6), p.612, Article 612</ispartof><rights>Copyright © 2020, Spandidos Publications.</rights><rights>COPYRIGHT 2021 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2021</rights><rights>Copyright © 2020, Spandidos Publications 2020</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-a7d2726785edcb3dcfd3a4038f2abd3cc78b62fa0dc3a1d0a762e9291b40e89e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082587/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082587/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33936269$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Neagu, Alexandra</creatorcontrib><creatorcontrib>Mocanu, Adela-Ioana</creatorcontrib><creatorcontrib>Bonciu, Alexandru</creatorcontrib><creatorcontrib>Coadă, Gabriella</creatorcontrib><creatorcontrib>Mocanu, Horia</creatorcontrib><title>Prevalence of GJB2 gene mutations correlated to presence of clinical and environmental risk factors in the etiology of congenital sensorineural hearing loss of the Romanian population</title><title>Experimental and therapeutic medicine</title><addtitle>Exp Ther Med</addtitle><description>Although etiologically heterogeneous at least 50% of all early on-set hearing losses have a genetic cause and of these, the large majority, 75-80% are most probably autosomal recessive and 70% are non-syndromic. The rest of the congenital hearing losses are determined by clinical and environmental factors such as ototoxic medication, prematurity, and complications at birth. During the last decade it became clear that 50-80% of all such afflictions result from mutations in a single gene,
, which encodes the protein Connexin 26. In order to, at least partially clarify this problem, especially in an emerging country such as Romania, where the problem is not studied adequately, we developed a comprehensive study of genetic, clinical and environmental risk factors for congenital hearing loss. The two most common variations of this gene,
and
in children with positive diagnosis of bilateral severe to profound sensorineural hearing loss were investigated. A cohort of 34 children (20 female and 14 male), ages between 2 and 10 (mean age 4.62 years), coming from 33 non-related families were evaluated. All cases were diagnosed with severe or profound bilateral congenital SNHL. A statistical comparison of genetic and environmental/clinical prevalence was also attempted since the presence of a genetic disorder cannot rule out the role of other documented risk factors in the etiology of SNHL. The results showed that, 29.4% of cases (10/34) were homozygotic for the
mutation
), also known as genotype Δ/Δ. 5.88% of cases (2/34) belong to the heterozygotic bi-genic group
. The clinical factors with high statistical significance for SNHL in a non-genetic group have no significance for genetic SNHL patients. Thus, the present study confirms the relatively high prevalence of the
and
mutations in cases of congenital non-syndromic severe of profound bilateral SNHL.</description><subject>Birth defects</subject><subject>Deafness</subject><subject>Environmental risk</subject><subject>Enzymes</subject><subject>Etiology</subject><subject>Families & family life</subject><subject>Gene mutations</subject><subject>Genes</subject><subject>Genetic aspects</subject><subject>Genotype & phenotype</subject><subject>Health aspects</subject><subject>Hearing disorders in children</subject><subject>Hearing loss</subject><subject>Hypoxia</subject><subject>Mutation</subject><subject>Parents & parenting</subject><subject>Pediatric research</subject><subject>Risk factors</subject><subject>Statistical analysis</subject><subject>Variables</subject><issn>1792-0981</issn><issn>1792-1015</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptkstu1DAUhiMEolXpliWyxIbNDL7EibNBKlVpQZVACNaWY59kXBJ7sJOR-mS8Xk-Gabmo9sK37_z2Of6L4iWja6Ea_hamcc0pZ2tGaVk-KY5Z3fAVo0w-Pcxpo9hRcZrzDcUmK6aUfF4cCdGIilfNcfHrS4KdGSBYILEjl5_ec9JDADLOk5l8DJnYmBIMZgJHpki2CfI9bQcfvDUDMcERCDufYhghTLiTfP5BOmOnmDLxgUwbIIB6Q-xv96Ex4DV-QVEux-QDzAlXGzA478kQc17AJfBrHE3wJpBt3M7D_lkvimedGTKcHsaT4vuHi2_nV6vrz5cfz8-uV7ZkclqZ2vGaV7WS4GwrnO2cMCUVquOmdcLaWrUV7wx1VhjmqKkrDg1vWFtSUA2Ik-Ldb93t3I6ogdnhK_U2-dGkWx2N1_-eBL_RfdxpRRWXqkaBNweBFH_OkCc9-mxhGEyAOGfNJWeSlkJwRF__h97EOQVMb6FKxqgU7A_V47dpH7qI99pFVJ9VFVeiYkIitX6Ewu5g9Fh86DzuPxZgE1Y-QfeQI6N6cZtGt-nFbXrvNgx49XdlHvB7b4k7DijUWA</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>Neagu, Alexandra</creator><creator>Mocanu, Adela-Ioana</creator><creator>Bonciu, Alexandru</creator><creator>Coadă, Gabriella</creator><creator>Mocanu, Horia</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210601</creationdate><title>Prevalence of GJB2 gene mutations correlated to presence of clinical and environmental risk factors in the etiology of congenital sensorineural hearing loss of the Romanian population</title><author>Neagu, Alexandra ; Mocanu, Adela-Ioana ; Bonciu, Alexandru ; Coadă, Gabriella ; Mocanu, Horia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-a7d2726785edcb3dcfd3a4038f2abd3cc78b62fa0dc3a1d0a762e9291b40e89e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Birth defects</topic><topic>Deafness</topic><topic>Environmental risk</topic><topic>Enzymes</topic><topic>Etiology</topic><topic>Families & family life</topic><topic>Gene mutations</topic><topic>Genes</topic><topic>Genetic aspects</topic><topic>Genotype & phenotype</topic><topic>Health aspects</topic><topic>Hearing disorders in children</topic><topic>Hearing loss</topic><topic>Hypoxia</topic><topic>Mutation</topic><topic>Parents & parenting</topic><topic>Pediatric research</topic><topic>Risk factors</topic><topic>Statistical analysis</topic><topic>Variables</topic><toplevel>online_resources</toplevel><creatorcontrib>Neagu, Alexandra</creatorcontrib><creatorcontrib>Mocanu, Adela-Ioana</creatorcontrib><creatorcontrib>Bonciu, Alexandru</creatorcontrib><creatorcontrib>Coadă, Gabriella</creatorcontrib><creatorcontrib>Mocanu, Horia</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental and therapeutic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Neagu, Alexandra</au><au>Mocanu, Adela-Ioana</au><au>Bonciu, Alexandru</au><au>Coadă, Gabriella</au><au>Mocanu, Horia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of GJB2 gene mutations correlated to presence of clinical and environmental risk factors in the etiology of congenital sensorineural hearing loss of the Romanian population</atitle><jtitle>Experimental and therapeutic medicine</jtitle><addtitle>Exp Ther Med</addtitle><date>2021-06-01</date><risdate>2021</risdate><volume>21</volume><issue>6</issue><spage>612</spage><pages>612-</pages><artnum>612</artnum><issn>1792-0981</issn><eissn>1792-1015</eissn><abstract>Although etiologically heterogeneous at least 50% of all early on-set hearing losses have a genetic cause and of these, the large majority, 75-80% are most probably autosomal recessive and 70% are non-syndromic. The rest of the congenital hearing losses are determined by clinical and environmental factors such as ototoxic medication, prematurity, and complications at birth. During the last decade it became clear that 50-80% of all such afflictions result from mutations in a single gene,
, which encodes the protein Connexin 26. In order to, at least partially clarify this problem, especially in an emerging country such as Romania, where the problem is not studied adequately, we developed a comprehensive study of genetic, clinical and environmental risk factors for congenital hearing loss. The two most common variations of this gene,
and
in children with positive diagnosis of bilateral severe to profound sensorineural hearing loss were investigated. A cohort of 34 children (20 female and 14 male), ages between 2 and 10 (mean age 4.62 years), coming from 33 non-related families were evaluated. All cases were diagnosed with severe or profound bilateral congenital SNHL. A statistical comparison of genetic and environmental/clinical prevalence was also attempted since the presence of a genetic disorder cannot rule out the role of other documented risk factors in the etiology of SNHL. The results showed that, 29.4% of cases (10/34) were homozygotic for the
mutation
), also known as genotype Δ/Δ. 5.88% of cases (2/34) belong to the heterozygotic bi-genic group
. The clinical factors with high statistical significance for SNHL in a non-genetic group have no significance for genetic SNHL patients. Thus, the present study confirms the relatively high prevalence of the
and
mutations in cases of congenital non-syndromic severe of profound bilateral SNHL.</abstract><cop>Greece</cop><pub>Spandidos Publications</pub><pmid>33936269</pmid><doi>10.3892/etm.2021.10044</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1792-0981 |
ispartof | Experimental and therapeutic medicine, 2021-06, Vol.21 (6), p.612, Article 612 |
issn | 1792-0981 1792-1015 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8082587 |
source | PubMed Central |
subjects | Birth defects Deafness Environmental risk Enzymes Etiology Families & family life Gene mutations Genes Genetic aspects Genotype & phenotype Health aspects Hearing disorders in children Hearing loss Hypoxia Mutation Parents & parenting Pediatric research Risk factors Statistical analysis Variables |
title | Prevalence of GJB2 gene mutations correlated to presence of clinical and environmental risk factors in the etiology of congenital sensorineural hearing loss of the Romanian population |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T13%3A49%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20GJB2%20gene%20mutations%20correlated%20to%20presence%20of%20clinical%20and%20environmental%20risk%20factors%20in%20the%20etiology%20of%20congenital%20sensorineural%20hearing%20loss%20of%20the%20Romanian%20population&rft.jtitle=Experimental%20and%20therapeutic%20medicine&rft.au=Neagu,%20Alexandra&rft.date=2021-06-01&rft.volume=21&rft.issue=6&rft.spage=612&rft.pages=612-&rft.artnum=612&rft.issn=1792-0981&rft.eissn=1792-1015&rft_id=info:doi/10.3892/etm.2021.10044&rft_dat=%3Cgale_pubme%3EA662836135%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2524110531&rft_id=info:pmid/33936269&rft_galeid=A662836135&rfr_iscdi=true |